RAMALINGAM Suresh | Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute
スポンサーリンク
概要
- RAMALINGAM Sureshの詳細を見る
- 同名の論文著者
- Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Instituteの論文著者
Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute | 論文
- Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection
- A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum